The discovery of new medicines
summary
Iktos explains how it uses AWS AI services and AWS support to train generative models and build a SaaS platform for pharmaceutical labs. The platform leverages those trained models to accelerate the discovery of new drug candidates.
AI-written summary · about
chapters (8)
- 0:00Introduction
- 2:52AWS and generative AI in healthcare
- 7:25Ictos and its role
- 10:33Generative models for medicinal chemistry
- 16:28Cloud migration with AWS
- 21:02Technical stack and architecture
- 25:58Automated lab and Ictos' future
- 27:24Conclusion
related talks
27mTransforming pharmaceutical R&D through industrialized machine learning
18mAPIs: ROI from artificial intelligence
20mExplore what’s possible with new AWS generative AI services
04mCustomer Spotlight
26mAccelerating innovation in the healthcare and life sciences industry
36mNew trends in data modernization: Catalysts for AI/ML analytics on AWS
30mFrom Code to Clinic — Building an Internal Developer Platform for Clinical AI
30mAI in Drug Discovery